SACK1A and breast cancer: Among them, FAM83A and NEK2 showed overexpression in BC (p > 0.001), high genetic alteration frequency (> 10%), high gene amplification rate, and an Oncoscore > 50, and therefore were selected for further investigation (Table 1 and Additional file 2: Fig. S2) [17–19].